NADMED Positioned Among Fastest-Growing Clinical Laboratory Tests

by Kai Herdin | Dec 13, 2024 | News

Research and Markets, one of the world’s leading market research firms, has identified NADMED as one of the fastest-growing clinical laboratory tests in Europe over the next five years. The molecular diagnostics segment, a key area of focus, is projected to achieve a...

NADMED Secures €3.5M to Accelerate International Sales Expansion

by Kai Herdin | Aug 22, 2024 | News

The investment round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured from previous investors Voima Ventures and University of Helsinki Funds, from a number of private European investors, and a grant...
Next Entries »

NADMED Ltd.

Biomedicum 2U
Tukholmankatu 8
00290 Helsinki
FINLAND

Office

+358 (0)10 375 1180
info@nadmed.com

Laboratory

+358 (0)10 375 1181
laboratory@nadmed.com
IN COLLABORATION WITH
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name

Copyright 2026 NADMED | Business ID: FI3259265–3 |  Privacy policy

Website: Amanda Visuals | Pete Productions